Alpha Tau Medical (DRTS) Current Assets (2020 - 2026)
Alpha Tau Medical (DRTS) posted Current Assets of $81.3 million for Q1 2026, up 3.9% sequentially from $78.3 million in Q4 2025, and up 43.25% YoY from $56.8 million in Q1 2025.
Alpha Tau Medical (DRTS) Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Current Assets for 7 years, with the latest figure at $81.3 million in Q1 2026.
- Quarterly Current Assets rose 43.25% year-over-year to $81.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.3 million (up 43.25% YoY) and the FY2025 annual result came in at $78.3 million, up 21.9% from the prior year.
- Current Assets rose to $81.3 million in Q1 2026 per DRTS's latest filing, from $78.3 million in the prior quarter.
- Over five years, Current Assets peaked at $111.2 billion in Q1 2022 and troughed at $56.8 million in Q1 2025.
- A 5-year average of $6.6 billion and a median of $85.8 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets jumped 226.21% in 2022, then sank 99.91% in 2023.
- Over 5 years, Current Assets stood at $106.5 million in 2022, then decreased by 19.46% to $85.8 million in 2023, then decreased by 25.1% to $64.2 million in 2024, then climbed by 21.9% to $78.3 million in 2025, then gained by 3.9% to $81.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $81.3 million, $78.3 million, and $77.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 106.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.83 Mn |
| Mar 31, 2026 | 81.35 Mn |
| Dec 31, 2025 | 78.30 Mn |
| Sep 30, 2025 | 77.10 Mn |
| Jun 30, 2025 | 85.78 Mn |
| Mar 31, 2025 | 56.79 Mn |
| Dec 31, 2024 | 64.23 Mn |
| Sep 30, 2024 | 69.79 Mn |
| Jun 30, 2024 | 75.25 Mn |
| Mar 31, 2024 | 81.20 Mn |
| Dec 31, 2023 | 85.76 Mn |
| Sep 30, 2023 | 91.44 Mn |
| Jun 30, 2023 | 96.06 Mn |
| Mar 31, 2023 | 101.02 Mn |
| Dec 31, 2022 | 106.48 Mn |
| Sep 30, 2022 | 111.33 Mn |
| Jun 30, 2022 | 116.03 Mn |
| Mar 31, 2022 | 111.20 Bn |
| Dec 31, 2021 | 32.64 Mn |
| Dec 31, 2020 | 47.46 Mn |